Q BioMed Inc.
OTC: QBIO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Denis D. Corin
- Employees
- 3
- Headquarters
- New York City, United States
- IPO year
- 2015
- Market cap
- $14.5K
- Website
- https://www.qbiomed.com
Loading QBIO…
Loading profile data…Frequently asked questions about QBIO
What does Q BioMed Inc. (QBIO) do?
Q BioMed Inc. functions as a biomedical accelerator and developer, actively licensing, acquiring, and supplying resources to firms within the life sciences and healthcare sectors. Its commercial portfolio includes Metastron (Strontium Chloride SR89), a radiopharmaceutical designed to alleviate pain associated with metastatic bone cancer. Additio...
Where does QBIO trade?
Q BioMed Inc. (QBIO) trades on the Other OTC.
What sector is QBIO in?
Q BioMed Inc. (QBIO) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Q BioMed Inc.?
Denis D. Corin is the chief executive officer of Q BioMed Inc. (QBIO).
Where is Q BioMed Inc. headquartered?
Q BioMed Inc. is headquartered in United States.
Does QBIO pay a dividend?
Q BioMed Inc. (QBIO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did QBIO go public?
Q BioMed Inc. (QBIO) completed its initial public offering in 2015.